Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease. Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
View Top Employees from Akebia TherapeuticsWebsite | http://www.akebia.com |
Ticker | AKBA |
Revenue | $207 million |
Funding | $100 million |
Employees | 352 (352 on RocketReach) |
Founded | 2007 |
Address | 245 First Street Suite 1400, Cambridge, Massachusetts 02142, US |
Phone | (617) 871-2098 |
Fax | (617) 871-2099 |
Technologies |
JavaScript,
HTML,
PHP
+55 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Health Care, Therapeutics |
Web Rank | 3 Million |
Keywords | Chronic Care, Kidney Care |
Competitors | Exelixis, Lexicon Pharmaceuticals, Inc., NGM Biopharmaceuticals, Puma Biotechnology, Inc., Reata Pharmaceuticals, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 325 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 32 Companies |
Looking for a particular Akebia Therapeutics employee's phone or email?
The Akebia Therapeutics annual revenue was $207 million in 2024.
Nikki Hadas is the Senior Vice President and General Counsel of Akebia Therapeutics.
352 people are employed at Akebia Therapeutics.
Akebia Therapeutics is based in Cambridge, Massachusetts.
The NAICS codes for Akebia Therapeutics are [3254, 541, 54, 54171, 325, 5417, 541714, 32].
The SIC codes for Akebia Therapeutics are [28, 283].